Abituzumab in SSc-ILD

Update Il y a 4 ans
Reference: EUCTR2015-005023-11

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the trial is to demonstrate efficacy of abituzumab in improving lung function of subjects with SSc-ILD.


Inclusion criteria

  • Systemic sclerosis-associated interstitial lung disease (SSc-ILD)

Links